Cysteinyl leukotriene receptor expression in aspirin-sensitive nasal polyposis patients

ORL

Volumn 69, Issue 3, 2007, Pages 176-180

  Ozen, Zeki ^a   Mumbuc, Semih ^b   Sari, Ibrahim ^b   Baglam, Tekin ^b   Karatas, Erkan ^b   Kanlikama, Muzaffer ^b  

^a MARDIN STATE HOSPITAL   (Turkey)

^b GAZIANTEP UNIVERSITY   (Turkey)

Author keywords

Aspirin sensitivity; Leukotriene receptors; Nasal polyposis

Indexed keywords

ACETYLSALICYLIC ACID; FORMALDEHYDE; PARAFFIN; PEPTIDOLEUKOTRIENE; POLYCLONAL ANTIBODY; RABBIT ANTISERUM;

ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; ENDOSCOPIC SURGERY; EOSINOPHIL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE; MACROPHAGE; MAJOR CLINICAL STUDY; MAST CELL; NEUTROPHIL; NOSE POLYP; PLASMA CELL; PRIORITY JOURNAL; RHINOSINUSITIS;

ASPIRIN; DRUG HYPERSENSITIVITY; ENDOSCOPY; EOSINOPHILS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOCYTES; MACROPHAGES; MAST CELLS; MEMBRANE PROTEINS; NASAL POLYPS; NEUTROPHILS; RECEPTORS, LEUKOTRIENE;

EID: 34247167208     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000099228     Document Type: Article

References (22)

1. Samter M, Beers RF Jr: Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med 1968;68:975-983.
2. Settipane GA, Lund VJ, Bernstein JM, Tos M: Nasal Polyps: Epidemiology, Pathogenesis and Treatment. Providence, Ocean Side Publications, Inc, 1997.
3. Szczeklik A, Nizankowska E, Serafin A, Dyczek A, Duplaga M, Musial J: Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med 1995;152:1753-1756.
4. Nasser SM, Lee TH: Leukotrienes in aspirin-sensitive asthma;in Szczeklik A, Gryglewski RJ, Vane J (eds): Eicosanoids, Aspirin and Asthma. New York, Dekker, 1998, pp 317-336.
5. Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis, diagnosis, and management. J Allergy Clin Immunol 2003;111:913-921.
6. Yoshimi R, Takamura H, Takasaki K, Tsurumoto H, Kumagami H: Immunohistological study of eosinophilic infiltration of nasal polyps in aspirin-induced asthma. Nippon Jibiinkoka Gakkai Kaiho 1993;96:1922-1925.
7. Yamashita T, Tsuji H, Maeda N, Tomoda K, Kumazawa T: Etiology of nasal polyps associated with aspirin-sensitive asthma. Rhinology 1989;8(suppl):15-24.
8. Kong H, Yang J, Dong Z, Yang Z, Pu G: Cell infiltration in nasal polyps and its pathological significance. Lin Chuang Er Bi Yan Hou Ke Za Zhi 1999;13:339-340.
9. Sriramarao P, von Andrian UH, Butcher EC, Bourdon MA, Broide DH: L-Selectin and very late antigen-4 integrin promote eosinophil rolling at physiological shear rates in vivo. J Immunol 1994;153:4238-4246.
10. Allen JS, Eisma R, Leonard G, Kreutzer D: Interleukin-3, interleukin-5, and granulocyte-macrophage colony-stimulating factor expression in nasal polyps. Am J Otolaryngol 1997;18:239-246.
11. Morita M, Lamkhioued B, Soussi Gounni A, et al: Induction by interferons of human eosinophil apoptosis and regulation by interleukin-3, granulocyte/macrophage-colony stimulating factor and interleukin-5. Eur Cytokine Netw 1996;7:725-732.
12. Perez-Novo CA, Kowalski ML, Kuna P, Ptasinska A, Holtappels G, van Cauwenberge P, Gevaert P, Johannson S, Bachert C: Aspirin sensitivity and IgE antibodies to Staphylococcus aureus enterotoxins in nasal polyposis: studies on the relationship. Int Arch Allergy Immunol 2004;133:255-260.
13. Bernstein JM, Ballow M, Schlievert PM, Rich G, Allen C, Dryja D: A superantigen hypothesis for the pathogenesis of chronic hyperplastic sinusitis with massive nasal polyposis. Am J Rhinol 2004;18:62.
14. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, Lam BK, Penrose JF, Austen FK, Holgate ST, Sampson AP: Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998;101:834-846.
15. Sanak M, Pierzchalska M, Bazan-Socha S, Szczeklik A: Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol 2000;23:273-276.
16. Szczeklik A, Stevenson DD: Aspirin-induced asthma: advances in pathogenesis and management. J Allergy Clin Immunol 1999;104:5-13.
17. Arm JP, Austen KF: Leukotriene receptors and aspirin sensitivity. N Engl J Med 2002;347:1524-1526.
18. Yoshida S, ?shizaki Y, Onuma K, Shoji T, Nakagawa A, Amaysu H: Selective cyclo-oxygenase 2 inhibitor in patients with aspirin-induced asthma. J Allergy Clin Immunol 2000;106:1201-1202.
19. Stevenson DD, Simon RA: Lack of cross-reactivity between rofecoxib and aspirin-sensitive patients with asthma. J Allergy Clin Immunol 2001;108:47-51.
20. Szczeklik A, Gryglewski RJ, Olszewski E, Debinska-Kiec A, Czerniawska-Mysik G: Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandin from nasal polyps. Pharmacol Res Commun 1977;9:415-425.
21. 2 and aspirin-induced asthma. Lancet 1995;345:1056.
22. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH: Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med 2002;347:1493-1499.